Role of TIM Molecules in Regulatory and Inflammatory B cells in Allo andAutoimmunity
TIM 分子在同种异体和自身免疫中调节性和炎症性 B 细胞中的作用
基本信息
- 批准号:10214475
- 负责人:
- 金额:$ 187.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdoptive TransferAllograft ToleranceAllograftingAnti-Inflammatory AgentsAntibodiesAntigen PresentationAutoantibodiesAutoimmuneAutoimmune DiabetesAutoimmune DiseasesAutoimmunityB-Lymphocyte SubsetsB-LymphocytesBiologyCellsCellular ImmunityChronicClinicalCuesDataDevelopmentExhibitsExperimental Autoimmune EncephalomyelitisGenesGenetic TranscriptionGraft RejectionHeart TransplantationHost DefenseHumanHumoral ImmunitiesImmune responseImmunoglobulin GInbred MRL lpr MiceInflammationInflammation MediatorsInflammatoryInflammatory ResponseInterferon Type IIInterleukin-10Interleukin-17Interleukin-6Kidney TransplantationLigationLinkLocationLupusMediatingModelingMusOutcomePathogenicityPatientsPhenotypePlayPopulationProductionRegulationRoleShapesSignal TransductionSurfaceT cell responseT-LymphocyteTestingTimeTransplant RecipientsTransplantationTransplantation ToleranceVascular Diseasesallograft rejectionanti-CD20autoimmune arthritisautoimmune inflammationbasebiomarker identificationclinically relevantcytokinefallsimmunoregulationimprovedinsightisoimmunitykidney allograftloss of functionmembermutantnovelpathogenic microbephenotypic biomarkerpreventprogenitorprogramsresponsetranscription factortranscriptome
项目摘要
In addition to humoral immunity, B cells play an important role shaping T effector responses through antigen
presentation, costimulation, and cytokine production. Thus, B cell depletion ameliorates autoimmune diabetes
and arthritis in mice, and rapidly improves RA and MS in humans, and outcomes do not correlate with fall in
autoantibodies. In contrast, in both humans and mice, B cell depletion can also worsen autoimmunity, and can
promote acute rejection and chronic vasculopathy in renal and cardiac transplant patients, respectively. These
studies indicate that B cells can either enhance, or inhibit, inflammatory responses. In this regard, transfer of
various B cell subsets can inhibit autoimmunity and allograft rejection through IL-10, and a growing list of other
mechanisms. However, lack of a universal phenotype or master transcription factor (TF) for these Bregs has
stymied the field. It is unknown whether these disparate cells are distinct or inter-related, or what regulates
their differentiation or cytokine expression. Our preliminary data show that: 1) TIM-1 is an inclusive marker for
IL-10+ Bregs. 2) Intact TIM-1 signaling on B cells regulates the expression of both TFs and various regulatory
molecules (“regulatory module”). This allows us to test their role in Breg differentiation and function. 3) We also
show that CpG-activated Pro-B cells transfer exceeding potent suppression, mediated by mature Breg progeny
exhibiting different mechanisms of action in different locations. Both progenitors and progeny are TIM-1+,
which allows us to examine the role of TIM-1 and TFs in Breg differentiation and regulatory module expression.
B cells can also express various proinflammatory cytokines in autoimmune and infectious settings that
strongly promote inflammatory responses. No phenotype for such effector B cells (Beff) has been established,
and it is unclear whether the various cells described, are distinct or inter-related. Major aspects of Beff biology
are completely unknown, including how differentiation and cytokine expression are regulated. We have
discovered that: 1) TIM-4 identifies Beff that express IFNγ and IL-17 and accelerate allograft rejection. 2) IL-17
is notably, both a potent effector cytokine, and is also required for development of the Beff inflammatory
program. Loss of B cell IL-17 not only reverses their inflammatory role, but also, inhibits the immune response,
promoting allograft tolerance. 3) TIM-4 ligation inhibits proinflammatory cytokine expression.
Based on our novel preliminary data, this PPG will utilize autoimmune and allograft models to test the
central hypothesis that TIM-1 and TIM-4, respectively, are unifying markers for Bregs and Beff and regulate
expression of TFs and other molecules important for their development and function. This will be addressed in
3 interactive and mutually supportive projects: Project 1: Role of Tim-1 and Bregs in Tolerance and Auto-
immunity; Project 2: Immunoregulation by TLR-activated TIM-1+ ProB Cells in Transplantation; and Project 3:
Inflammatory B Cells Defined by TIM-4 in the Alloimmune Response. This understanding is key to developing
clinically relevant approaches to selectively target Beff and Bregs to enhance or inhibit the immune response.
除了体液免疫外,B 细胞通过抗原在塑造 T 效应反应中发挥着重要作用
呈现、共刺激和细胞因子的产生。因此,B 细胞耗竭可改善自身免疫性糖尿病
和小鼠关节炎,并迅速改善人类的 RA 和 MS,并且结果与下降无关
自身抗体。相比之下,在人类和小鼠中,B 细胞耗竭也会恶化自身免疫,并可能
分别促进肾移植和心脏移植患者的急性排斥反应和慢性血管病变。这些
研究表明 B 细胞可以增强或抑制炎症反应。对此,转让
各种 B 细胞亚群可以通过 IL-10 以及越来越多的其他细胞抑制自身免疫和同种异体移植排斥
机制。然而,这些 Breg 缺乏通用表型或主转录因子 (TF)
阻碍了该领域。目前尚不清楚这些不同的细胞是否不同或相互关联,或者是什么调节
它们的分化或细胞因子表达。我们的初步数据表明:1)TIM-1 是一个包容性标记
IL-10+ 布雷格斯。 2) B 细胞上完整的 TIM-1 信号传导调节 TF 和各种调节因子的表达
分子(“调节模块”)。这使我们能够测试它们在 Breg 分化和功能中的作用。 3)我们也
显示 CpG 激活的 Pro-B 细胞转移超过由成熟 Breg 后代介导的有效抑制
不同部位表现出不同的作用机制。祖代和子代都是TIM-1+,
这使我们能够检查 TIM-1 和 TF 在 Breg 分化和调节模块表达中的作用。
B 细胞还可以在自身免疫和感染环境中表达各种促炎细胞因子,
强烈促进炎症反应。尚未确定此类效应 B 细胞 (Beff) 的表型,
目前还不清楚所描述的各种细胞是不同的还是相互关联的。 Beff 生物学的主要方面
完全未知,包括如何调节分化和细胞因子表达。我们有
发现:1) TIM-4 识别表达 IFNγ 和 IL-17 并加速同种异体移植排斥的 Beff。 2) IL-17
值得注意的是,它既是一种有效的效应细胞因子,也是 Beff 炎症发展所必需的
程序。 B 细胞 IL-17 的缺失不仅会逆转其炎症作用,还会抑制免疫反应,
促进同种异体移植耐受。 3) TIM-4 连接抑制促炎细胞因子的表达。
基于我们新的初步数据,该 PPG 将利用自身免疫和同种异体移植模型来测试
中心假设 TIM-1 和 TIM-4 分别是 Bregs 和 Beff 的统一标记并调节
转录因子和其他对其发育和功能重要的分子的表达。这将在
3 个互动且相互支持的项目: 项目 1:Tim-1 和 Bregs 在宽容和自动中的作用
免疫;项目2:TLR激活的TIM-1+ ProB细胞在移植中的免疫调节;和项目 3:
同种免疫反应中 TIM-4 定义的炎症 B 细胞。这种理解是发展的关键
临床相关方法选择性地针对 Beff 和 Bregs 以增强或抑制免疫反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID M ROTHSTEIN其他文献
DAVID M ROTHSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID M ROTHSTEIN', 18)}}的其他基金
Role of TIM Molecules in Regulatory and Inflammatory B cells in Allo andAutoimmunity
TIM 分子在同种异体和自身免疫中调节性和炎症性 B 细胞中的作用
- 批准号:
9751742 - 财政年份:2018
- 资助金额:
$ 187.07万 - 项目类别:
Inflammatory B cells defined by TIM-4 in the Alloimmune response
同种免疫反应中 TIM-4 定义的炎症 B 细胞
- 批准号:
10214481 - 财政年份:2018
- 资助金额:
$ 187.07万 - 项目类别:
Immunoregulation by TLR-activated TIM-1+ ProB Cells in Transplantation
TLR 激活的 TIM-1 ProB 细胞在移植中的免疫调节
- 批准号:
10455069 - 财政年份:2018
- 资助金额:
$ 187.07万 - 项目类别:
Immunoregulation by TLR-activated TIM-1+ ProB Cells in Transplantation
TLR 激活的 TIM-1 ProB 细胞在移植中的免疫调节
- 批准号:
10214480 - 财政年份:2018
- 资助金额:
$ 187.07万 - 项目类别:
Role of TIM Molecules in Regulatory and Inflammatory B cells in Allo andAutoimmunity
TIM 分子在同种异体和自身免疫中调节性和炎症性 B 细胞中的作用
- 批准号:
10455065 - 财政年份:2018
- 资助金额:
$ 187.07万 - 项目类别:
Inflammatory B cells defined by TIM-4 in the Alloimmune response
同种免疫反应中 TIM-4 定义的炎症 B 细胞
- 批准号:
10455071 - 财政年份:2018
- 资助金额:
$ 187.07万 - 项目类别:
Inflammatory B Cells Defined by TIM-4 in the Alloimmune Response
TIM-4 在同种免疫反应中定义的炎症 B 细胞
- 批准号:
9542016 - 财政年份:2017
- 资助金额:
$ 187.07万 - 项目类别:
In Vivo Detection And Mechanisms Of Regulatory B Cell Function In Transplantation
移植中调节性 B 细胞功能的体内检测和机制
- 批准号:
9197259 - 财政年份:2015
- 资助金额:
$ 187.07万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 187.07万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 187.07万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 187.07万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 187.07万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 187.07万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 187.07万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 187.07万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 187.07万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 187.07万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 187.07万 - 项目类别:
Research Grant














{{item.name}}会员




